PROM1 and lung cancer: The fact that the pharmacological blockade of the Notch-1 pathway by DAPT prevented the enrichment of CD133+ cells induced by cisplatin, suggested that this pathway might constitute a key component in the CSC phenotype appearance induced by chronic exposure to cisplatin in lung cancer.